id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1996-P-0045-0005,FDA,FDA-1996-P-0045,Duplicate -FDA,Notice,NCR-Notice of Correction,2002-03-19T05:00:00Z,2002,3,,,2025-01-17T19:45:13Z,,0,0,09000064804fc727
FDA-1996-P-0045-0004,FDA,FDA-1996-P-0045,Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph; Correction,Notice,NCR-Notice of Correction,2002-03-19T05:00:00Z,2002,3,2002-03-15T05:00:00Z,,2025-01-17T19:37:21Z,02-6180,0,0,09000064804fc726
FDA-1996-P-0045-0003,FDA,FDA-1996-P-0045,Duplicate - FDA,Notice,NFR-Notice of Final Rule,2002-02-19T05:00:00Z,2002,2,,,2025-01-17T18:32:40Z,,0,0,09000064804fc725
FDA-1996-P-0045-0002,FDA,FDA-1996-P-0045,Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph,Notice,Notice of Final Rule,2002-02-19T05:00:00Z,2002,2,2002-02-08T05:00:00Z,,2025-01-17T18:30:46Z,02-3079,0,0,09000064804fc724
FDA-1996-P-0045-0001,FDA,FDA-1996-P-0045,Topical Antifungal Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph,Notice,NPR-Notice of Proposed Rule-Making,2001-05-29T04:00:00Z,2001,5,2001-05-29T04:00:00Z,,2025-01-17T17:59:16Z,01-13299,0,0,09000064804fc69b